Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/18133
Title: Hepatitis C in European prisons: a call for an evidence-informed response
Authors: ARAIN, Amber 
ROBAEYS, Geert 
Stöver, Heino
Issue Date: 2014
Publisher: BIOMED CENTRAL LTD
Source: BMC INFECTIOUS DISEASES, 14 (S6)
Abstract: Globally, over 10 million people are held in prisons and other places of detention at any given time. People who inject drugs (PWID) comprise 10-48% of male and 30-60% of female prisoners. The spread of hepatitis C in prisons is clearly driven by injection drug use, with many infected prisoners unaware of their infection status. Risk behaviour for acquisition of hepatitis C via common use of injecting equipment is widespread in many prison settings. In custodial settings, effective and efficient prevention models applied in the community are very rarely implemented. Only approximately 60 out of more than 10,000 prisons worldwide provide needle exchange. Thus, HCV prevention is almost exclusively limited to verbal advice, leaflets and other measures directed to cognitive behavioural change. Although the outcome of HCV antiviral treatment is comparable to non-substance users and substance users out of prison, the uptake for antiviral treatment is extremely low. Based on a literature review to assess the spread of hepatitis C among prisoners and to learn more about the impact for the prison system, recommendations regarding hepatitis C prevention, screening and treatment in prisons have been formulated in this article.
Notes: [Arain, Amber; Robaeys, Geert] Hasselt Univ, Fac Med & Life Sci, Limburg Clin Res Programme, Hasselt, Belgium. [Robaeys, Geert] Ziekenhuis Oost Limburg, Dept Gastroenterol & Hepatol, Genk, Belgium. [Robaeys, Geert] Leuven Univ, Univ Hosp Leuven, Dept Hepatol, Leuven, Belgium. [Stoever, Heino] Univ Appl Sci, Fac Hlth & Social Work, Frankfurt, Germany.
Document URI: http://hdl.handle.net/1942/18133
e-ISSN: 1471-2334
DOI: 10.1186/1471-2334-14-S6-S17
ISI #: 000345662100017
Rights: © 2014 Arain et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Category: A1
Type: Journal Contribution
Validations: ecoom 2016
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
1471-2334-14-S6-S17.pdf164.94 kBAdobe PDFView/Open
Show full item record

SCOPUSTM   
Citations

22
checked on Sep 2, 2020

WEB OF SCIENCETM
Citations

31
checked on May 21, 2022

Page view(s)

40
checked on May 19, 2022

Download(s)

84
checked on May 19, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.